phosphorylcholine has been researched along with Body Weight in 13 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Daily dosing over 28 days in rats resulted in mild to moderate, unilateral or bilateral erosion/ulceration of the olfactory epithelium, frequently with minimal to mild, acute to sub-acute inflammation of the lamina propria at the dorsal turbinates of the nasal cavity in 2/10 males and 3/10 females in the high-dose group (0." | 1.42 | A novel nasal powder formulation of glucagon: toxicology studies in animal models. ( Carballo, D; McInally, K; Normand, P; Piché, C; Reno, FE; Silo, S; Stotland, P; Triest, M, 2015) |
| "To estimate drug costs of treating visceral leishmaniasis (VL) based on data on the VL population structure from the high-burden, antimony-resistant area of Northern Bihar, India." | 1.35 | Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India. ( Olliaro, P; Sundar, S, 2009) |
| " However, the concept of clinical trials requires new approaches to dose finding and response evaluation, because the dose-response relationship of this compound is distinctly different from that of classical cytostatic agents." | 1.30 | D-21266, a new heterocyclic alkylphospholipid with antitumour activity. ( Engel, J; Hilgard, P; Klenner, T; Kutscher, B; Nössner, G; Stekar, J, 1997) |
| " The pharmacokinetic parameters after a single intravenous dose of 40 mg/kg were calculated using a two-compartment model: C(max) = 1." | 1.30 | Erucylphosphocholine: pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration. ( Eibl, H; Erdlenbruch, B; Gerriets, A; Jendrossek, V; Lakomek, M; Vetterlein, F, 1999) |
| " Single administration of equimolar HePC doses results in differing pharmacokinetic values for free HePC (p." | 1.29 | Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine. ( Berger, MR; Drevs, J; Eibl, H; Kaufmann-Kolle, P; Kötting, J; Marschner, N; Unger, C, 1994) |
| "The histopathological change from tubular adenocarcinoma to malignant adenoacanthoma might be caused by an overgrowth of the primary epithelial tumor cells or by a real transformation in the morphological characteristics of the tumor, which may occur during repeated transplantation." | 1.28 | Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats. ( Amelung, F; Berger, MR; Heyl, P; Reinhardt, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| de Santana, FR | 1 |
| da Silva, DAM | 1 |
| Katz, S | 1 |
| Orikaza, CM | 1 |
| Oliveira, KC | 1 |
| Barbiéri, CL | 1 |
| Oyama, T | 1 |
| Takeuchi, H | 1 |
| Matsuda, S | 1 |
| Ozawa, S | 1 |
| Kitajima, M | 1 |
| Kitagawa, Y | 1 |
| Reno, FE | 1 |
| Normand, P | 1 |
| McInally, K | 1 |
| Silo, S | 1 |
| Stotland, P | 1 |
| Triest, M | 1 |
| Carballo, D | 1 |
| Piché, C | 1 |
| Olliaro, P | 1 |
| Sundar, S | 1 |
| Bianciardi, P | 1 |
| Brovida, C | 1 |
| Valente, M | 1 |
| Aresu, L | 1 |
| Cavicchioli, L | 1 |
| Vischer, C | 1 |
| Giroud, L | 1 |
| Castagnaro, M | 1 |
| Yan, G | 1 |
| Zhao, Y | 1 |
| Deng, P | 1 |
| Lv, L | 1 |
| Wang, Y | 1 |
| Bu, Q | 1 |
| Liu, B | 1 |
| Hu, C | 1 |
| Zhuo, Y | 1 |
| Yang, X | 1 |
| Wang, L | 1 |
| Cen, X | 1 |
| Kim, YI | 1 |
| Miller, JW | 1 |
| da Costa, KA | 1 |
| Nadeau, M | 1 |
| Smith, D | 1 |
| Selhub, J | 1 |
| Zeisel, SH | 1 |
| Mason, JB | 1 |
| Kaufmann-Kolle, P | 1 |
| Drevs, J | 1 |
| Berger, MR | 2 |
| Kötting, J | 1 |
| Marschner, N | 1 |
| Unger, C | 1 |
| Eibl, H | 2 |
| Dixon, RM | 1 |
| Tian, M | 1 |
| Hilgard, P | 1 |
| Klenner, T | 1 |
| Stekar, J | 1 |
| Nössner, G | 1 |
| Kutscher, B | 1 |
| Engel, J | 1 |
| Husain, AN | 1 |
| Siddiqui, NH | 1 |
| Stocker, JT | 1 |
| Erdlenbruch, B | 1 |
| Jendrossek, V | 1 |
| Gerriets, A | 1 |
| Vetterlein, F | 1 |
| Lakomek, M | 1 |
| Reinhardt, M | 1 |
| Heyl, P | 1 |
| Amelung, F | 1 |
13 other studies available for phosphorylcholine and Body Weight
| Article | Year |
|---|---|
A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Body Weight; Cricetinae; Leishmania infantum; Leishmania | 2022 |
Translymphatic chemotherapy targeting sentinel lymph nodes using a novel phospholipid polymer-Paclitaxel conjugate.
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Cell Line, Tumor; Cell Survival; Disease Mo | 2014 |
A novel nasal powder formulation of glucagon: toxicology studies in animal models.
Topics: Administration, Intranasal; Animals; Area Under Curve; beta-Cyclodextrins; Body Weight; Dogs; Female | 2015 |
Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India.
Topics: Adolescent; Adult; Age Distribution; Aged; Amphotericin B; Anthropometry; Antiprotozoal Agents; Body | 2009 |
Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys.
Topics: Animals; Antiprotozoal Agents; Body Weight; Dogs; Female; Fluorescent Antibody Technique; Histocytoc | 2009 |
Investigation of toxicological effects of Shuanghuanglian injection in Beagle dogs by metabonomic and traditional approaches.
Topics: Anemia, Hemolytic; Animals; Biomarkers; Body Weight; Choline; Dogs; Drugs, Chinese Herbal; Injection | 2010 |
Severe folate deficiency causes secondary depletion of choline and phosphocholine in rat liver.
Topics: Animals; Body Weight; Choline; Diet; Folic Acid; Folic Acid Deficiency; Homocysteine; Liver; Male; P | 1994 |
Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Chromatography, High Pressure Liq | 1994 |
Phospholipid synthesis in the lymphomatous mouse liver studied by 31P nuclear magnetic resonance spectroscopy in vitro and by administration of 14C-radiolabelled compounds in vivo.
Topics: Animals; Body Weight; Carbon Radioisotopes; Choline; Ethanolamine; Ethanolamines; Liver Neoplasms; L | 1993 |
D-21266, a new heterocyclic alkylphospholipid with antitumour activity.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Body Weight; Dose-Response Relatio | 1997 |
Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia.
Topics: Biological Products; Body Weight; Bronchopulmonary Dysplasia; Drug Combinations; Fatty Alcohols; Fem | 1998 |
Erucylphosphocholine: pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration.
Topics: Animals; Antineoplastic Agents; Blood Glucose; Body Weight; Brain; Injections, Intravenous; Leukocyt | 1999 |
Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biomarkers, Tumor; Body Weight; Female; Keratins; Ma | 1992 |